Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-19

Clinical Trial Update: Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 randomized trial in renal transplant recipients comparing mycophenolate mofetil with delayed sirolimus and discontinuation of cyclosporine to a regimen …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)
  • Mycophenolate mofetil (CellCept) (mycophenolate mofetil)
  • Sirolimus (Rapamune) (Sirolimus)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED